Lag-3 signaling-suppression of CTL activity in tumors (97, 98). Blocking of PD-L1, CTLA-4 and Lag-3—effective and enduring immunotherapy for disseminated leukemia in murine model (98). Here, CTLA4 is linked to leukemia.